Glaucoma Research Foundation meets the 20 Standards for Charity Accountability.
Glaucoma Research Foundation (GRF) works to encourage innovative research toward better treatments for people with glaucoma. The organization's Catalyst for a Cure program is a research collaboration involving scientists at four different institutions discovering ways to restore vision and cure glaucoma. GRF's Glaucoma 360 is a three-day series of meetings and events aimed at stimulating interest and speeding the translation of new drugs and devices into clinical use to help glaucoma patients preserve and restore vision. The organization's pilot project grants provide one-year seed money for research to better understand and treat glaucoma. GRF also publishes brochures, newsletters, booklets, and a website to increase awareness and knowledge of glaucoma and glaucoma research among patients, families and the general public.
For the year ended June 30, 2019, Glaucoma Research Foundation's program expenses were:
Research |
$2,334,960 |
Education |
$1,257,323 |
Total Program Expenses: |
$3,592,283 |
-
Chief Executive
Thomas M. Brunner, President and Chief Executive Officer
-
Compensation*
$253,782
-
Chair of the Board
Andrew Iwach
-
Chair's Profession / Business Affiliation
Executive Director, Glaucoma Center of San Francisco
-
Board Size
14
-
Paid Staff Size
10
*2018 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Planned giving arrangements
Fundraising costs were 21% of related contributions. (Related contributions, which totaled $2,462,979, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Glaucoma Research Foundation's audited financial statements for the year ended June 30, 2019.
Source of Funds |
Donations and bequests |
$1,872,259 |
Conference/forum income |
$602,319 |
Special events income |
$590,720 |
Investment income |
$505,392 |
Other revenue |
$22,103 |
Total Income |
$3,592,793 |
- Programs: 83%
- Fundraising: 12%
- Administrative: 5%
Total Income |
$3,592,793 |
Program expenses |
$3,592,283 |
Fundraising expenses |
$514,780 |
Administrative expenses |
$258,558 |
Other expenses |
$0 |
Total expenses: |
$4,365,621 |
Income in Excess of Expenses |
$-772,828 |
Beginning Net Assets |
$11,011,311 |
Other Changes In Net Assets |
$10,075 |
Ending Net Assets |
$10,248,558 |
Total Liabilities |
$728,352 |
Total Assets |
$10,976,910 |
Note: In the financial section above, 'other changes in net assets' refers to a change in value in charitable trusts.